NASDAQ:AVTX | ROE | Avalo Therapeutics, Inc.

Complete source-backed roe history.

Available history
2013-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-22.36%
2026-03-31-124.03%
2025-12-31-94.23%
2025-09-30-109.10%
2025-06-30-44.19%
2025-03-3159.55%
2024-12-31-26.41%
2024-09-30-37.76%
2024-06-30266.19%
2024-03-31126.96%
2023-12-31-431.87%
2023-09-30-225.85%
2023-06-30355.40%
2023-03-31471.71%
2022-12-31381.66%
2022-09-302516.86%
2022-06-301203.65%
2022-03-31-1194.37%
2021-12-31-365.55%
2021-09-30-200.51%
2021-06-30-356.16%
2021-03-31-220.37%
2020-12-31-258.53%
2020-09-30-119.88%
2020-06-30-72.75%
2020-03-31-116.21%
2019-12-31-76.55%
2019-09-30-127.61%
2019-06-30-247.73%
2019-03-31-188.68%
2018-12-31-191.57%
2018-09-30-192.67%
2018-06-3029.86%
2018-03-3140.47%
2017-12-3142.61%
2017-09-3060.23%
2017-06-30-368.89%
2017-03-313122.01%
2016-12-31-7957.22%
2016-09-30-3149.39%
2016-06-30-233.42%
2016-03-31-139.54%
2015-12-31-80.18%
2015-09-3028.51%

Annual ROE

DateROE
2025-12-31-94.23%
2024-12-31-26.41%
2023-12-31-431.87%
2022-12-31381.66%
2021-12-31-365.55%
2020-12-31-258.53%
2019-12-31-76.55%
2018-12-31-191.57%
2017-12-3142.61%
2016-12-31-7957.22%
2015-12-31-80.18%
2014-12-3160.98%
2013-12-3173.09%